Zhengye Biotechnology Holding Ltd. ZYBT

$4.80 +1.03 (27.32%)

Valuation

Market cap
—
Revenue TTM
$211,651,000
Net income TTM
$31,457,000
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
1,650,324
Avg volume
—
Day's range
$3.70 – $6.10
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabie...

Show more

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
86 432 6304 7008
Website
https://www.jlzybio.com
Address
No.1 Lianmeng Road, Jilin Eco & Technical Dev Zn, Jilin, China

Latest news

No headlines yet.